Global expression and functional analysis of human piRNAs during HSV-1 infection.


Journal

Virus research
ISSN: 1872-7492
Titre abrégé: Virus Res
Pays: Netherlands
ID NLM: 8410979

Informations de publication

Date de publication:
15 04 2023
Historique:
received: 11 11 2022
revised: 18 02 2023
accepted: 06 03 2023
pubmed: 10 3 2023
medline: 22 3 2023
entrez: 9 3 2023
Statut: ppublish

Résumé

Piwi-interacting RNAs (piRNAs) are a class of non-coding RNAs that play a key role in spermatogenesis. However, little is known about their expression characterization and role in somatic cells infected with herpes simplex virus type 1 (HSV-1). In this study, we systematically investigated the cellular piRNA expression profiles of HSV-1-infected human lung fibroblasts. Compared with the control group, 69 differentially expressed piRNAs were identified in the infection group, among which 52 were up-regulated and 17 were down-regulated. The changes in the expression of 8 piRNAs were further verified by RT-qPCR with a similar expression trend. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis showed that the target genes of piRNAs were mainly involved in antiviral immunity and various human disease-related signaling pathways. Furthermore, we tested the effects of four up-regulated piRNAs on viral replication by transfecting piRNA mimics. The results showed that the virus titers of the group transfected with piRNA-hsa-28,382 (alias piR-36,233) mimic decreased significantly, and that of the group transfected piRNA-hsa-28,190 (alias piR-36,041) mimic significantly increased. Overall, our results revealed the expression characteristics of piRNAs in HSV-1-infected cells. We also screened two piRNAs that potentially regulate HSV-1 replication. These results may promote a better understanding of the regulatory mechanism of pathophysiological changes induced by HSV-1 infection.

Identifiants

pubmed: 36894069
pii: S0168-1702(23)00049-7
doi: 10.1016/j.virusres.2023.199087
pmc: PMC10194222
pii:
doi:

Substances chimiques

Piwi-Interacting RNA 0
RNA, Small Interfering 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

199087

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Nucleic Acids Res. 2022 Jan 7;50(D1):D326-D332
pubmed: 34718726
PLoS Biol. 2004 Nov;2(11):e363
pubmed: 15502875
Mol Cells. 2019 Dec 31;42(12):828-835
pubmed: 31838836
Nucleic Acids Res. 2019 Jan 8;47(D1):D175-D180
pubmed: 30371818
Arch Virol. 2020 Jan;165(1):105-114
pubmed: 31741095
Viruses. 2022 Jul 28;14(8):
pubmed: 36016282
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3734-3739
pubmed: 30808759
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Viruses. 2021 Aug 31;13(9):
pubmed: 34578321
Front Cell Neurosci. 2019 Feb 26;13:46
pubmed: 30863282
Curr Protoc Bioinformatics. 2010 Dec;Chapter 11:Unit 11.7
pubmed: 21154709
Vaccine. 2016 Jun 3;34(26):2948-2952
pubmed: 26973067
PLoS One. 2012;7(2):e30619
pubmed: 22312429
Curr Opin Virol. 2017 Jun;24:97-104
pubmed: 28538165
J Virol. 2015 Dec 09;90(5):2240-53
pubmed: 26656717
Cell Physiol Biochem. 2018;47(5):2031-2045
pubmed: 29972822
Nature. 2006 Jul 13;442(7099):203-7
pubmed: 16751777
Annu Rev Pathol. 2017 Jan 24;12:245-275
pubmed: 27959635
Virol Sin. 2021 Aug;36(4):736-745
pubmed: 33616891
Cold Spring Harb Perspect Biol. 2014 Aug 01;6(8):
pubmed: 25085912
Biophys J. 2016 Jan 5;110(1):218-33
pubmed: 26745425
Nucleic Acids Res. 2003 Jan 1;31(1):439-41
pubmed: 12520045
Nucleic Acids Res. 2008 Jan;36(Database issue):D154-8
pubmed: 17991681
Nat Ecol Evol. 2018 Jan;2(1):174-181
pubmed: 29203920
Genes Dev. 2002 Nov 1;16(21):2733-42
pubmed: 12414724
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Curr Biol. 2001 Jul 10;11(13):1017-27
pubmed: 11470406
Curr Opin Virol. 2011 Oct;1(4):226-32
pubmed: 22440781
Bull World Health Organ. 2020 May 01;98(5):315-329
pubmed: 32514197
Nat Rev Genet. 2019 Feb;20(2):89-108
pubmed: 30446728
Cell. 2021 Jul 8;184(14):3774-3793.e25
pubmed: 34115982
Lancet. 2001 May 12;357(9267):1513-8
pubmed: 11377626
ACS Nano. 2020 Aug 25;14(8):10616-10623
pubmed: 32806067
Antiviral Res. 2020 Apr;176:104754
pubmed: 32114034
Cell Calcium. 2009 Jul;46(1):1-17
pubmed: 19535138
Hum Vaccin Immunother. 2020 Oct 2;16(10):2389-2402
pubmed: 32078405
PLoS Pathog. 2016 Dec 29;12(12):e1006017
pubmed: 28033427
Curr Opin Virol. 2018 Oct;32:9-14
pubmed: 30015014
Nucleic Acids Res. 2015 Jul 27;43(13):6545-56
pubmed: 26068474
Parasit Vectors. 2014 Apr 10;7:177
pubmed: 24721600
Nature. 2006 Jul 13;442(7099):199-202
pubmed: 16751776
Pediatrics. 2007 Feb;119(2):e399-407
pubmed: 17272602
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4
pubmed: 16381832

Auteurs

Xu Wang (X)

Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.

Pu Huang (P)

Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.

Mengyue Lei (M)

Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.

Ying Ma (Y)

Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China.

Hongli Chen (H)

Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China; Kunming Medical University, Kunming, Yunnan, China.

Jing Sun (J)

Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China. Electronic address: jingzikm@imbcams.com.cn.

Yunzhang Hu (Y)

Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China. Electronic address: huyunzhang@imbcams.com.cn.

Jiandong Shi (J)

Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China. Electronic address: shijiandong@imbcams.com.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH